FDA approves Erbitux to treat late-stage head and neck cancer
Links shared publicly online about this topic.
- 0total visits
FDA approves Erbitux to treat late-stage head and neck cancer
fda.gov —
View full resource at fda.gov
Tags: Cancer, Chemotherapy, Head and Neck Cancer, Diet and Nutrition, Drug, FDA, Erbitux
Most Recently Shared on November 8, 2011 at 2:56 pm By:
FDA approves Erbitux to treat late-stage head and neck cancer: http://t.co/YhEHVgKu
Also Shared By:
FDA Approves Cetuximab for Late-Stage Head and Neck Cancer | Oral Cancer News
oralcancernews.org — “FDA Approves Cetuximab for Late-Stage Head and Neck Cancer | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on November 9, 2011 at 1:05 pm By:
The Oral Cancer Foundation Health Organization
OCF News Update: FDA Approves Cetuximab for Late-Stage Head and Neck Cancer http://t.co/eNzD7u7b
Erbitux (Cetuximab) Approved For Metastatic Head And Neck Cancer, USA
medicalnewstoday.com — “Erbitux (cetuximab) has been approved by the US FDA for combination use with chemotherapy for late-stage head and neck cancer treatment. When given together with chemotherapy, Erbitus was found to” View full resource at medicalnewstoday.com
Most Recently Shared on November 8, 2011 at 7:05 am By:
MNT Drug Approvals Health News
Erbitux (cetuximab) Approved For Metastatic Head And Neck Cancer, USA http://t.co/zZZhKwbc #regulatory
Advertisement
NCI Cancer Bulletin
@NCIBulletin
FDA approves Erbitux, in combination w/ chemotherapy, to treat late-stage head & neck cancer (release) http://t.co/bMtFRAyA
1 year ago...